Back
NeuroPace 10K Form
Sell
32
NPCE
NeuroPace
Last Price:
$11.28
Seasonality Move:
-26.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NPCE News And Ratings
See the #1 stock for the next 7 days that we like better than NPCE
NPCE Financial Statistics
Sales & Book Value
| Annual Sales: | $79.9M |
|---|---|
| Cash Flow: | $-4.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.27 |
| Price / Book: | 43.63 |
Profitability
| EPS (TTM): | -0.95000 |
|---|---|
| Net Income (TTM): | $-27.1M |
| Gross Margin: | $59.1M |
| Return on Equity: | -216.38% |
| Return on Assets: | -27.59% |
NeuroPace Earnings Forecast
Key NeuroPace Financial Ratios
-
The Gross Profit Margin over the past 6 years for NPCE is 73.94%.
-
The Selling, General & Administrative Expenses for NPCE have been equal to 71.46% of Gross Profit Margin.
-
The Research & Development expenses have been 29.60% of Revenue.
-
The Net Earning history of NPCE is -33.97% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 4 years.
NeuroPace Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NPCE |
| Website: | neuropace.com |
Debt
| Debt-to-Equity Ratio: | 7.43 |
|---|---|
| Current Ratio: | 5.37 |
| Quick Ratio: | 4.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |